SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-20-000595
Filing Date
2020-06-18
Accepted
2020-06-18 16:09:02
Documents
1
Period of Report
2020-06-16

Document Format Files

Seq Description Document Type Size
1 vaxcyte_fm4jun1620.html 4  
1 vaxcyte_fm4jun1620.xml 4 21018
  Complete submission text file 0000905718-20-000595.txt   22423
Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SAN FRANCISCO CA 94080
Business Address
EMSTER KURT VON (Reporting) CIK: 0001252524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 20972570

Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)